Thermo Fisher Scientific Supports Sepsis Awareness Outreach to Spanish Speakers
September 18, 2014
WALTHAM, Mass. -- Thermo Fisher Scientific, in partnership with the Sepsis Alliance, has extended its sepsis awareness outreach to Spanish-speaking communities. The Company provided funding to enable translation and subtitling for the Sepsis Alliance video “Sepsis: Emergency” as part of its Sepsis Awareness Month initiative. “We are also proud of our partnership with Sepsis Alliance, [...]
September 18, 2014
Torrance, CA -– Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, announces the addition of a 5 µm particle size to its family of Aeris PEPTIDE core-shell columns, enabling higher efficiencies and higher loading capability for small-scale peptide purification in 10 mm ID semi-prep columns and [...]
HORIBA Scientific Expands FluoroMax Series with New FluoroMax Plus
September 18, 2014
HORIBA Scientific, global leader in Fluorescence spectroscopy systems, recently launched the new FluoroMax Plus, a convenient, affordable, and easy-to-use benchtop spectrofluorometer. The new FluoroMax Plus expands on the already class-leading capabilities of our FluoroMax series with the option of a second detector and two position grating turret, providing an extended range out to 1650 nm, [...]
September 18, 2014
CARLSBAD, Calif. -- Thermo Fisher Scientific today announced that it has completed the listing of its Ion PGM Dx next generation sequencing system with the U.S. Food and Drug Administration (FDA) for clinical use as a class II medical device. “Next generation sequencing is rapidly becoming an indispensable tool for clinical laboratories around the world, [...]
SeqLL Closes Series-A Funding Round for Expansion of Single Molecule Sequencing
September 18, 2014
Woburn, MA -- SeqLL Inc., the owner of the True Single Molecule Sequencing (tSMS™) technology, announced today the closing of a $1M Series-A funding round. This round of investment, led by Genomic Diagnostic Technologies, will increase the power of tSMS™ technology for scientific and diagnostic applications. Founded in March 2013 by Daniel Jones, a former [...]
September 17, 2014
Sunnyvale, CA -- Freeslate, Inc., the leading provider of high throughput research solutions for drug development, today announced that Baylor University acquired a Freeslate Core Module 3 (CM3) Reaction Screening System to both support Baylor research interests and provide screening services to the Texas community. Freeslate’s high throughput system is expected to significantly accelerate innovation [...]
PaR Systems, Inc. Opens New Subsidiary in Toulouse, France
September 17, 2014
SHOREVIEW, Minn. -- PaR Systems, Inc. (https://www.par.com), a world leader in aerospace manufacturing, material handling, automation, and robotic solutions since 1961, announced today that it has opened a facility in Toulouse, France. The new facility, PaR Robotique SARL, opened on July 1, 2014, will provide European customers with the same high level of service and [...]
Bruker Introduces New Products for Preclinical Imaging at WMIC 2014
September 17, 2014
SEOUL, South Korea -- At the 2014 World Molecular Imaging Congress (WMIC, www.wmis.org), Bruker today introduces new products for improved performance and customer experience in preclinical imaging, and announces related achievements: NEW PRODUCT: SkyScan™ 1278, the world’s fastest, low-dose, high-resolution micro-CT: With the launch of the next-generation SkyScan 1278 micro-CT system for in vivo X-ray [...]
Thermo Fisher Scientific, UC San Diego Announce Duane Roth Innovation Grant
September 17, 2014
CARLSBAD, Calif. -- "Its purpose is to inspire San Diego-based scientists to innovate and collaborate on research projects that ultimately will drive science and technology forward to better understand human disease. These are foundational principles that Duane worked hard to promote in Southern California." Thermo Fisher Scientific and the UC San Diego Office of Research [...]
September 17, 2014
ALAMEDA, Calif. & JERUSALEM -- BioTime, Inc. (NYSE MKT: BTX), HBL Hadasit Bio-Holdings Ltd. (Tel Aviv Stock Exchange: HDST) and Cell Cure Neurosciences Ltd. (Cell Cure) today announced that Cell Cure has received the final results of a series of extensive preclinical safety and efficacy studies of its development-stage product designated OpRegen®, which is intended [...]
